MWA
DGX icon

Meridian Wealth Advisors’s Quest Diagnostics DGX Stock Holding History

Meridian Wealth Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,251
Closed -$216K – 213
2021
Q4 		$216K Buy
+1,251
New +$190K 0.05% 185
2019
Q1 		– Sell
-1,251
Closed -$104K – 193
2018
Q4 		$104K Buy
+1,251
New +$117K 0.08% 163

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Meridian Wealth Advisors's DGX Position: Q1 2022 in Review

Meridian Wealth Advisors sold out of Quest Diagnostics (DGX) in Q1 2022, closing a stake of 1,251 shares — an estimated $216K sold.

Meridian Wealth Advisors first reported a position in DGX in Q4 2018 and held it in 2 quarters. The position peaked at $216K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • Meridian Wealth Advisors reported no remaining Quest Diagnostics position as of Q1 2022 after selling out during the quarter.
  • Meridian Wealth Advisors sold 1,251 Quest Diagnostics shares in Q1 2022, an estimated $216K.
  • Meridian Wealth Advisors first reported a position in Quest Diagnostics in Q4 2018 and held it in 2 quarters.
  • Meridian Wealth Advisors's Quest Diagnostics position peaked at $216K in Q4 2021.
  • 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on Meridian Wealth Advisors's 13F filing for Q1 2022, filed 12 May 2022.